All news from Anaesthesiology

New Class Of Drugs May Lower Heart Disease Risk By Targeting Gut Microbes

Researchers have designed a potential new class of drugs that may reduce cardiovascular risk by targeting a specific microbial pathway in the gut. Unlike antibiotics, which non-specifically kill gut bacteria and can lead to adverse side effects and resistance, the new class of compounds prevents microbes from making a harmful molecule linked to heart disease without killing the microbes, which are part of the gut flora and may be beneficial to overall health. The study was published in Nature Medicine.

Sleeping Longer Than Eight Hours Leads To Greater Risk

A large study led by Keele University has found that sleeping longer than eight hours is more harmful than sleeping less than seven hours. The study also found that a sleep duration of ten hours is linked with a 30% increased risk of dying compared to sleeping for seven hours.

A global study led by Keele University has found that people who sleep for more than eight hours a night have a greater mortality and cardiovascular risk than those who sleep for under seven hours. The study also found that a sleep duration of ten hours is linked with a 30% increased risk of dying compared to sleeping for seven hours. 

The study, published in the Journal of the American Heart Association, examined the link between self-reported sleep and cardiovascular disease and mortality in more than three million participants.

Robotic Soft Spider: Movement and Operation at Small Size Scale made Easy

Roboticists are envisioning a future in which soft, animal-inspired robots could be safely deployed in difficult-to-access natural and man-made environments, such as in delicate surgical procedures in the human body, or in spaces too small and unpredictable to be conquered with rigid robots or too dangerous for humans to work with rigid robots in.

Centimeter-sized soft robots have been created, but thus far it has not been possible to fabricate multifunctional flexible robots that can move and operate at smaller size scales.

Rational Vaccine Design accelerated with a New Antibody Analysis, Study

A team at Scripps Research has come up with a faster way to analyze the outcome of experimental vaccines against HIV and other pathogens. Their new system lets scientists quickly assess the full spectrum of antibodies produced in an individual in response to a pathogen or vaccine and determine if these antibodies are likely to be effective against the pathogen.